Biosimilars: Where Do We Stand?

Primary tabs

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, what are the ethical implications of these products?  How will they impact clinical supply chain?  What are the financial implications?  Join a panel of experts as they explore these and other questions on biosimilars during this luncheon seminar.

Amir Emamifar, PharmD - Associate Administrator Pharmaceutical Services, Emory Healthcare
Yaniv Heled, JSD, LLM - Assistant Professor of Law, Georgia State University College of Law
Ashish Dugar PhD, MBA - Head, Medicines Development Group, Biosimilars Business Unit, Pfizer

Joel Zivot, MD, FRCP – Assistant Professor Anesthesiology & Surgery, Emory University School of Medicine, and Medical Director, Cardiothoracic ICU, Emory University Hospital Midtown

1.5 hours ACHE Qualified Education Credit (formerly “Category 2”)

Download the Flyer for more details & speaker biographies


Registrations for this event are being collected by the Georgia Association of Healthcare Executives. CLICK HERE TO REGISTER.

ACHE/GaBio Member ..... $35
Non-Member ................ $45
Student Member .......... $20
Student Non-Member..... $25

For information contact: GAHE Administrator Karen Manno or call 678-264-8354

A joint program with the Georgia Association of Healthcare Executives


  • Workflow Status: Published
  • Created By: Colly Mitchell
  • Created: 09/17/2012
  • Modified By: Fletcher Moore
  • Modified: 10/07/2016

Target Audience

No target audience selected.